$18.71
0.170.92%
At close: -
$18.71
0.000.00%
After Hours: 4:00 PM EDT
Kiniksa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-29 | $-0.18 | $0.03 | -700.0 % |
Q2 | 2024-07-23 | $-0.06 | $-0.07 | 14.3 % |
Q1 | 2024-04-23 | $-0.25 | $-0.16 | -56.3 % |
Q4 | 2024-02-28 | $0.35 | $-0.14 | 350.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-29 | $112.21M | $111.52M | 0.62 % |
Q2 | 2024-07-23 | $108.63M | $92.31M | 17.7 % |
Q1 | 2024-04-23 | $79.86M | $78.46M | 1.78 % |
Q4 | 2024-02-28 | $83.40M | $72.02M | 15.8 % |
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on April 22, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $-0.18, which missed the estimate of $0.03.
The Actual Revenue was $112.2M, which beat the estimate of $111.5M.
Browse earnings estimates, EPS, and revenue on all stocks.